There is one big difference between Vimovo/Trex and PA. The difference is which tier it will land in for co-pay. PA will be priced a lot less. I believe Vimovo is priced too high. The generics must believe there is a significant market, even at generic type prices.
PA's problem will be to get the doctor's attention via the social media strategy.